Elevation of systemic matrix metalloproteinases 2 and 7 and tissue inhibitor of metalloproteinase 2 in patients with a history of Achilles tendon rupture: pilot study

Objectives In this study, serum levels of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) between patients with a history of Achilles tendon rupture and blood donor controls were compared, and their relation to mechanical properties of the tendons during healing were studied. Methods More than 3 years after injury, serum levels of MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9 and MMP-13, TIMP-1 and TIMP-2 in eight patients who had Achilles tendon rupture were measured. Twelve blood donors served as controls. During the early phase of healing, the tendon modulus of elasticity was calculated from radiostereometric data and tendon cross-sectional area. Results Patients with a history of Achilles tendon rupture had increased levels of MMP-2 (median difference 10%, p=0.01), MMP-7 (median difference 15%, p=0.02) and TIMP-2 (median difference 36%, p=0.02), compared with controls. Levels of MMP-7, measured 3 years after injury, correlated inversely to tendon modulus of elasticity (rs=20.83, p=0.02) and positively to tendon elongation (rs=0.74, p=0.05) during the early phase of healing. There was a trend towards positive correlation between MMP-7 and cross-sectional area during the early phase of healing (rs=0.67, p=0.08). Conclusions Patients with a history of Achilles tendon rupture appear to have elevated levels of MMP-2, MMP-7 and TIMP-2 in serum. In these pilot data, the view that the MMP–TIMP system is involved in tendinopathy is supported and that disturbances in proteolytic control might be generalised are suggested.

[1]  N. Maffulli,et al.  Collagens, Proteoglycans, MMP-2, MMP-9 and TIMPs in Human Achilles Tendon Rupture , 2008, Clinical orthopaedics and related research.

[2]  J. Kvist,et al.  Mechanical properties during healing of Achilles tendon ruptures to predict final outcome: A pilot Roentgen stereophotogrammetric analysis in 10 patients , 2007, BMC musculoskeletal disorders.

[3]  K. Jung.  Preanalytical biases in measurement of matrix metalloproteinases and their tissue inhibitors in peripheral blood. , 2007, The Journal of rheumatology.

[4]  A. Bayat,et al.  Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor , 2007, Annals of the rheumatic diseases.

[5]  Malcolm Collins,et al.  Tendon and ligament injuries: the genetic component , 2007, British Journal of Sports Medicine.

[6]  A. N. Corps,et al.  Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. , 2006, Arthritis and rheumatism.

[7]  A. N. Corps,et al.  Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. , 2006, Rheumatology.

[8]  S. Weiss,et al.  Matrix metalloproteinases and failed fracture healing. , 2005, Bone.

[9]  U. Klinge,et al.  Changes of the extracellular matrix as a risk factor for anastomotic leakage after large bowel surgery. , 2005, Surgery.

[10]  Pankaj Sharma,et al.  Tendon injury and tendinopathy: healing and repair. , 2005, The Journal of bone and joint surgery. American volume.

[11]  P. Aspelin,et al.  Tendon injury and repair after core biopsies in chronic Achilles tendinosis evaluated by serial magnetic resonance imaging , 2004, British Journal of Sports Medicine.

[12]  A. Carr,et al.  Genetic influences in the aetiology of tears of the rotator cuff. Sibling risk of a full-thickness tear. , 2004, The Journal of bone and joint surgery. British volume.

[13]  T. Wobbes,et al.  Circulating matrix metalloproteinase-9 is transiently elevated after colorectal surgery , 2004, International Journal of Colorectal Disease.

[14]  R. Bahr,et al.  Contralateral tendon rupture risk is increased in individuals with a previous Achilles tendon rupture , 2004, Scandinavian journal of medicine & science in sports.

[15]  G. Riley,et al.  The pathogenesis of tendinopathy. A molecular perspective. , 2004, Rheumatology.

[16]  P. Ohtonen,et al.  Rerupture and Deep Infection Following Treatment of Total Achilles Tendon Rupture , 2002, The Journal of bone and joint surgery. American volume.

[17]  J. Karlsson,et al.  A Radiographic and Histologic Evaluation of the Patellar Tendon after Harvesting Its Central Third* , 2000, The American journal of sports medicine.

[18]  J. Leppilahti,et al.  Outcome and Prognostic Factors of Achilles Rupture Repair Using a New Scoring Method , 1998, Clinical orthopaedics and related research.

[19]  M J Campbell,et al.  Statistics in Medicine: Calculating confidence intervals for some non-parametric analyses , 1988 .

[20]  Erasmus Mc,et al.  Changes in Biochemical Composition and Collagen Turnover Rate , 2009 .

[21]  Pippa Simpson,et al.  Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens , 2006, Clinical chemistry and laboratory medicine.

[22]  G. Cockrell,et al.  Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex® Multiplex technology , 2005, Clinical chemistry and laboratory medicine.

[23]  J. D. Visser,et al.  [Achilles tendon rupture]. , 1980, Nederlands tijdschrift voor geneeskunde.